UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-Sensitivity Troponins in Cardiovascular Disease

Current cardiology reports, 2020-03, Vol.22 (5), p.30-30, Article 30

2020

Volltextzugriff (PDF)

Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study

Journal of cardiovascular pharmacology, 2016-06, Vol.67 (6), p.544-551

2016

Volltextzugriff (PDF)

PROGRESSIVE CONDUCTION DISEASE IN A TRANSPLANTED HEART: A CASE OF REACTIVATED TRYPANOSOMA CRUZI INFECTION

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.2257

2022

Volltextzugriff (PDF)

Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI)

Circulation (New York, N.Y.), 2024-08, Vol.150 (7), p.580-582

2024

Volltextzugriff (PDF)

BOTH THE POISON AND THE CURE: TORSADES DE POINTES INDUCED BY CHEMOTHERAPEUTIC ARSENIC TRIOXIDE

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.3869-3869

2023

Volltextzugriff (PDF)

Abstract 211: Long-Term Mortality in Diabetic Patients with Non-Obstructive Coronary Disease Undergoing Coronary Angiography/Cardiac Catheterization

Arteriosclerosis, thrombosis, and vascular biology, 2016-05, Vol.36 (suppl_1)

2016

Volltextzugriff (PDF)

Abstract 370: Contrast-Induced Nephropathy and Long-Term Outcomes in Patients With Diabetes Undergoing Coronary and Peripheral Angiography and Intervention

Arteriosclerosis, thrombosis, and vascular biology, 2017-05, Vol.37 (suppl_1)

2017

Volltextzugriff (PDF)

Abstract 16959: Interleukin-1 Blockade in Acute Decompensated Systolic Heart Failure: Results of the Anakinra in Decompensated Heart Failure Pilot Study

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A16959-A16959

2015

Volltextzugriff (PDF)

Sepsis-Induced Cardiomyopathy: a Comprehensive Review

Current cardiology reports, 2020-05, Vol.22 (5), p.35-35, Article 35

2020

Volltextzugriff (PDF)

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction

Scientific reports, 2022-01, Vol.12 (1), p.1254-1254, Article 1254

2022

Volltextzugriff (PDF)

Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction

Journal of the American Heart Association, 2020-03, Vol.9 (5), p.e014941-e014941

2020

Volltextzugriff (PDF)

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

Journal of translational medicine, 2022-06, Vol.20 (1), p.270-270, Article 270

2022

Volltextzugriff (PDF)

Abstract 17996: One-Year Outcomes of Patients With ST-Segment Elevation Myocardial Infarction According to Eosinophil Blood Count

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

Journal of cardiovascular pharmacology, 2020-10, Vol.77 (1), p.49-60

2020

Volltextzugriff (PDF)

STEMI AND ARTERIAL THROMBI FOLLOWING SYNTHETIC MARIJUANA USE

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.2425-2425

2020

Volltextzugriff (PDF)

Abstract 16312: Sex-Based Differences in Response to Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Myocardial Infarction

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction

Journal of the American Heart Association, 2023-09, Vol.12 (18), p.e031251-e031251

2023

Volltextzugriff (PDF)

Abstract 13994: Time to Treatment and Efficacy of IL-1 Blockade With Anakinra in ST-Segment Elevation Myocardial Infarction

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Clinical and Pharmacological Implications of Time to Treatment with Interleukin-1 Blockade in ST-Segment Elevation Myocardial Infarction

The Journal of pharmacology and experimental therapeutics, 2023-08, Vol.386 (2), p.156-163

2023

Volltextzugriff (PDF)

Effect of IL-1 Blockade With Anakinra on Heart Failure Outcomes in Patients With Anterior Versus Nonanterior ST Elevation Myocardial Infarction

Journal of cardiovascular pharmacology, 2022-06, Vol.79 (6), p.774-780

2022

Volltextzugriff (PDF)

Response to Interleukin-1 Blockade With Anakinra in Black and White Americans With ST-Segment Elevation Myocardial Infarction

The American journal of cardiology, 2023-11, Vol.207, p.336-338

2023

Volltextzugriff (PDF)

400.13 Premedication with Steroids and Short-Term and Long-Term Renal Outcomes After Coronary and Peripheral Angiography and Intervention

JACC. Cardiovascular interventions, 2019-02, Vol.12 (4), p.S38-S38

2019

Volltextzugriff (PDF)

100.46 Intravenous Fluid Therapy Is Associated With a Reduced Incidence of Contrast-Induced Nephropathy But Not With a Reduced Long-Term Incidence of Renal Dysfunction After Cardiac Catheterization and Coronary Intervention

JACC. Cardiovascular interventions, 2019-02, Vol.12 (4), p.S14-S14

2019

Volltextzugriff (PDF)

Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure

The American journal of cardiology, 2016-01, Vol.117 (1), p.116-120

2016

Volltextzugriff (PDF)

Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials

European heart journal. Cardiovascular pharmacotherapy, 2022-08, Vol.8 (5), p.503-510

2022

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High-Sensitivity Troponins in Cardiovascular Disease

Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study

PROGRESSIVE CONDUCTION DISEASE IN A TRANSPLANTED HEART: A CASE OF REACTIVATED TRYPANOSOMA CRUZI INFECTION

Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI)

BOTH THE POISON AND THE CURE: TORSADES DE POINTES INDUCED BY CHEMOTHERAPEUTIC ARSENIC TRIOXIDE

Abstract 211: Long-Term Mortality in Diabetic Patients with Non-Obstructive Coronary Disease Undergoing Coronary Angiography/Cardiac Catheterization

Abstract 370: Contrast-Induced Nephropathy and Long-Term Outcomes in Patients With Diabetes Undergoing Coronary and Peripheral Angiography and Intervention

Abstract 16959: Interleukin-1 Blockade in Acute Decompensated Systolic Heart Failure: Results of the Anakinra in Decompensated Heart Failure Pilot Study

Sepsis-Induced Cardiomyopathy: a Comprehensive Review

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction

Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

Abstract 17996: One-Year Outcomes of Patients With ST-Segment Elevation Myocardial Infarction According to Eosinophil Blood Count

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

STEMI AND ARTERIAL THROMBI FOLLOWING SYNTHETIC MARIJUANA USE

Abstract 16312: Sex-Based Differences in Response to Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Myocardial Infarction

Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction

Abstract 13994: Time to Treatment and Efficacy of IL-1 Blockade With Anakinra in ST-Segment Elevation Myocardial Infarction

Clinical and Pharmacological Implications of Time to Treatment with Interleukin-1 Blockade in ST-Segment Elevation Myocardial Infarction

Effect of IL-1 Blockade With Anakinra on Heart Failure Outcomes in Patients With Anterior Versus Nonanterior ST Elevation Myocardial Infarction

Response to Interleukin-1 Blockade With Anakinra in Black and White Americans With ST-Segment Elevation Myocardial Infarction

400.13 Premedication with Steroids and Short-Term and Long-Term Renal Outcomes After Coronary and Peripheral Angiography and Intervention

100.46 Intravenous Fluid Therapy Is Associated With a Reduced Incidence of Contrast-Induced Nephropathy But Not With a Reduced Long-Term Incidence of Renal Dysfunction After Cardiac Catheterization and Coronary Intervention

Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure

Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials

Suchergebnisse filtern